Form 8-K ANTARES PHARMA, INC. For: Aug 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St rises as chip stocks' gains offset Middle East jitters
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil eases as investors assess US-Iran peace prospects
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Antares Pharma's (ATRS) CFO Resigns
August 11, 2016 7:15 AM EDTAntares Pharma (NASDAQ: ATRS) disclosed in an SEC filing:
On August 5, 2016, Antares Pharma, Inc. (the Company) received a written notice of resignation from James E. Fickenscher, the Companys Senior Vice President and Chief Financial Officer. Mr. Fickenschers resignation will become effective September 4, 2016.... More
